One-step partial synthesis of (±)-asperteretone B and related hPTP1B 1-400 inhibitors from butyrolactone I.

Protein tyrosine phosphatase 1B (PTP1B) is a validated target for developing antiobesity, antidiabetic and anticancer drugs. Over the past years, several inhibitors of PTP1B have been discovered; however, none has been approved by the drug regulatory agencies. Interestingly, the research programs focused on discovering PTP1B inhibitors typically use truncated structures of the protein (PTP1B _1-300 , 1-300 amino acids), leading to the loss of valuable information about the inhibition and selectivity of ligands and repeatedly misleading the optimization of putative drug leads. Up to date, only six inhibitors of the full-length protein (hPTP1B _1-400 ), with affinity constants ranging from 1.3 × 10 ⁴ to 3.3 × 10 ⁶ M ^-1 , have been reported. Towards the discovery of new ligands of the full-length human PTP1B (hPTP1B _1-400 ) from natural sources, herein we describe the isolation of a γ-lactone (1, butyrolactone I) from the fungus Aspergillus terreus, as well as the semisynthesis, inhibitory properties (in vitro and in silico), and the structure-activity relationship of a set of butyrolactone derivatives (1 and 2, and 6-12) as hPTP1B _1-400 inhibitors, as well as the affinity constant (k _a  = 2.2 × 10 ⁵ M ^-1 ) of the 1-hPTP1B ₁ - ₄₀₀ complex, which was determined by fluorescence quenching experiments, after the inner filter effect correction.
(Copyright © 2020 Elsevier Ltd. All rights reserved.)